164 related articles for article (PubMed ID: 32763234)
21. Continuous infusion versus intermittent infusion vancomycin in a burn center intensive care unit.
Schlobohm CJ; Zhu E; Duby JJ
Burns; 2021 Nov; 47(7):1495-1501. PubMed ID: 34538672
[TBL] [Abstract][Full Text] [Related]
22. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
Truong J; Levkovich BJ; Padiglione AA
Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of and maintenance dose recommendations for vancomycin in severe pneumonia patients undergoing continuous venovenous hemofiltration with the combination of predilution and postdilution.
Li Q; Liang F; Sang L; Li P; Lv B; Tan L; Liu X; Chen W
Eur J Clin Pharmacol; 2020 Feb; 76(2):211-217. PubMed ID: 31734748
[TBL] [Abstract][Full Text] [Related]
24. Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy.
Akers KS; Cota JM; Chung KK; Renz EM; Mende K; Murray CK
J Burn Care Res; 2012; 33(6):e254-62. PubMed ID: 22878490
[TBL] [Abstract][Full Text] [Related]
25. Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients.
Pea F; Furlanut M; Negri C; Pavan F; Crapis M; Cristini F; Viale P
Antimicrob Agents Chemother; 2009 May; 53(5):1863-7. PubMed ID: 19223642
[TBL] [Abstract][Full Text] [Related]
26. Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients.
Medellín-Garibay SE; Romano-Moreno S; Tejedor-Prado P; Rubio-Álvaro N; Rueda-Naharro A; Blasco-Navalpotro MA; García B; Barcia E
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893792
[TBL] [Abstract][Full Text] [Related]
27. [Dosage adjustment of vancomycin in continuous infusion in critically ill-patients].
Carricajo A; Forgeot A; Morel J; Auboyer C; Zeni F; Aubert G
Ann Fr Anesth Reanim; 2010 Jan; 29(1):55-7. PubMed ID: 20074899
[TBL] [Abstract][Full Text] [Related]
28. Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study.
Bakke V; Sporsem H; Von der Lippe E; Nordøy I; Lao Y; Nyrerød HC; Sandvik L; Hårvig KR; Bugge JF; Helset E
Acta Anaesthesiol Scand; 2017 Jul; 61(6):627-635. PubMed ID: 28444760
[TBL] [Abstract][Full Text] [Related]
29. New Regimen for Continuous Infusion of Vancomycin in Critically Ill Patients.
Cristallini S; Hites M; Kabtouri H; Roberts JA; Beumier M; Cotton F; Lipman J; Jacobs F; Vincent JL; Creteur J; Taccone FS
Antimicrob Agents Chemother; 2016 Aug; 60(8):4750-6. PubMed ID: 27216073
[TBL] [Abstract][Full Text] [Related]
30. Continuous Versus Intermittent Infusion of Vancomycin and the Risk of Acute Kidney Injury in Critically Ill Adults: A Systematic Review and Meta-Analysis.
Flannery AH; Bissell BD; Bastin MT; Morris PE; Neyra JA
Crit Care Med; 2020 Jun; 48(6):912-918. PubMed ID: 32317590
[TBL] [Abstract][Full Text] [Related]
31. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
[TBL] [Abstract][Full Text] [Related]
32. Vancomycin continuous infusion versus intermittent infusion during continuous venovenous hemofiltration: slow and steady may win the race.
Lin H; Bukovskaya Y; De Moya M; Lee J; Schmidt U
Ann Intensive Care; 2015; 5():10. PubMed ID: 25995967
[TBL] [Abstract][Full Text] [Related]
33. High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.
Pea F; Porreca L; Baraldo M; Furlanut M
J Antimicrob Chemother; 2000 Mar; 45(3):329-35. PubMed ID: 10702552
[TBL] [Abstract][Full Text] [Related]
34. Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients.
Chung J; Oh JM; Cho EM; Jang HJ; Hong SB; Lim CM; Koh YS
Anaesth Intensive Care; 2011 Nov; 39(6):1030-7. PubMed ID: 22165354
[TBL] [Abstract][Full Text] [Related]
35. Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study.
Wysocki M; Delatour F; Faurisson F; Rauss A; Pean Y; Misset B; Thomas F; Timsit JF; Similowski T; Mentec H; Mier L; Dreyfuss D
Antimicrob Agents Chemother; 2001 Sep; 45(9):2460-7. PubMed ID: 11502515
[TBL] [Abstract][Full Text] [Related]
36. Drug use density in critically ill children and newborns: analysis of various methodologies.
Valcourt K; Norozian F; Lee H; Raszynski A; Torbati D; Totapally BR
Pediatr Crit Care Med; 2009 Jul; 10(4):495-9. PubMed ID: 19451853
[TBL] [Abstract][Full Text] [Related]
37. [PK/PD of vancomycin in patients with severe acute pancreatitis combined with augmented renal clearance].
He J; Mao E; Jing F; Jiang H; Xu W; Yang W; Chen E
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):810-814. PubMed ID: 28936957
[TBL] [Abstract][Full Text] [Related]
38. The dosing and monitoring of vancomycin: what is the best way forward?
Drennan PG; Begg EJ; Gardiner SJ; Kirkpatrick CMJ; Chambers ST
Int J Antimicrob Agents; 2019 Apr; 53(4):401-407. PubMed ID: 30599240
[TBL] [Abstract][Full Text] [Related]
39. Comparison of intermittent versus continuous vancomycin infusion for the treatment of late-onset sepsis in preterm infants.
Demirel B; İmamoglu E; Gursoy T; Demirel U; Topçuoglu S; Karatekin G; Ovali F
J Neonatal Perinatal Med; 2015; 8(2):149-55. PubMed ID: 26410440
[TBL] [Abstract][Full Text] [Related]
40. [Level of evidence for therapeutic drug monitoring of vancomycin].
Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM;
Therapie; 2011; 66(1):29-37. PubMed ID: 21466775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
